CONTINUE TO SITE
OR WAIT null SECS
- Advertise
- Contact Us
- Editorial
- Editorial Board
- Do Not Sell My Personal Information
- Privacy
- Terms and Conditions
© 2022 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
Delft takes majority interest in Rogan
Delft Instruments has increased its interest in Rogan Medical Systems from 35% to 52%. Rogan, which markets its PACS software worldwide under the name HyperPACS, will continue to trade as a separate Delft operating company. Rogan already
Delft Instruments has increased its interest in Rogan Medical Systems from 35% to 52%. Rogan, which markets its PACS software worldwide under the name HyperPACS, will continue to trade as a separate Delft operating company. Rogan already collaborates with two other Delft companies: Nucletron for radiotherapy and thorax imaging and Oldelft Benelux for equipment distribution and maintenance.